APA (7th ed.) Citation

TA, G., S, V., BJ, J., RJ, D., R, P., AF, C., . . . S, A. (2026). MYCN drives pediatric glioma transformation from neural progenitors and creates distinct therapeutic vulnerabilities. Cell reports, 45(6), 117522. https://doi.org/10.1016/j.celrep.2026.117522

Chicago Style (17th ed.) Citation

TA, Gatesman, et al. "MYCN Drives Pediatric Glioma Transformation from Neural Progenitors and Creates Distinct Therapeutic Vulnerabilities." Cell Reports 45, no. 6 (2026): 117522. https://doi.org/10.1016/j.celrep.2026.117522.

MLA (9th ed.) Citation

TA, Gatesman, et al. "MYCN Drives Pediatric Glioma Transformation from Neural Progenitors and Creates Distinct Therapeutic Vulnerabilities." Cell Reports, vol. 45, no. 6, 2026, p. 117522, https://doi.org/10.1016/j.celrep.2026.117522.